Canada has planned to ship 800 vials of its Ebola vaccine to the World Health Organization (WHO) in Geneva to curb the outbreak of the disease.
The experimental vaccines will be distributed by WHO in the countries most affected by the disease, the Public Health Agency of Canada announced.
“The vaccine is undergoing clinical trials on humans at Walter Reed Army Institute of Research in the United States after showing promising results in animal testing,” the agency explained.
As the vaccine is experimental, researchers are not able to predict how many people could be immunized or treated.
The vaccine was developed at Canada’s National Microbiology Laboratory in Winnipeg, Manitoba.
More than 4,500 people, most of them in the West African countries, had lost their lives to Ebola which was first confirmed in March.
Nearly half of the deaths have reportedly occurred in Liberia. The UN health agency said that data gathering problems in the African country had made it difficult for officials to draw exact numbers or conclusions on Ebola.
Ebola is a form of hemorrhagic fever whose symptoms are diarrhea, vomiting and bleeding. The virus spreads through direct contact with infected blood, feces or sweat.
It can also be spread through sexual contact or the unprotected handling of contaminated corpses. There is currently no known cure for Ebola.
- Taxpayer funded Canadian state TV releases "whites must extinct" propaganda rap song
- Rare 'Thunderstorm Asthma' Kills Six in Australia
- Sen. D'Amato: Hillary Allowed Russia to Take Ownership of US Uranium to Sell to Iran
- Bilderberg Planning to Trigger Financial Collapse
- Canada Legalizes Bestiality With Pets